Eli Lilly said its next generation weight-loss drug retatrutide resulted in significant weight loss and reduced knee pain in ...

The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...

Lilly’s closely watched retatrutide spurred as much as 29% weight loss in a Phase 3 study, a finding that is “raising the bar ...

The larger risk reductions were not explained by changes in LDL cholesterol, suggesting something else is at play.

By Maggie Fick LONDON, Dec 11 (Reuters) - Zealand Pharma plans to launch five obesity and related drugs by 2030 as the Danish ...

Soybean oil is regarded as beneficial to health, but this study suggests that you can have too much of a good thing and ...

Soybean oil, used for cooking in more than half of American households, is linked to a higher risk of obesity in a new study.

Visceral obesity is associated with increased left ventricular mass and reduced ventricular volumes — suggesting concentric ...

Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too ...

Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term imaging and plasma data show that obese individuals experience much faster ...

For insufficient sleep prevalence in adults, Tennessee ranked No. 7 with a rate of 39.6%. Overall, Tennessee was ranked No. 5 ...